查询词典 p-isopropylbenzylidene

In this paper, we introduce the concepts of the great common P-divisor, least common P-multiple of two distinct nonzero elements x, y in arbitrary unique factorization domain R, and denote them byp, and p respectively.

在本文中，作为通常的整数环Z上的最大公因子和最小公倍数的推广，我们在惟一分解整环R上定义了最大公P-因子和最小公P-倍元，分别记为_P和_P。

At last, the similar metric p' is given on MV unit interval, and it's proved that p' is the usual metric.

最后，在MV单位区间上引入了类似p的一个度量p'，并证明了([0， 1]， p')是通常度量空间。

The results show that there were no significant differences among the four forage rations in rumen pH, the concentrations of total volatile fatty acids, acetate, propionate, the ratios of acetate to propionate, butyrate, isobutyrate and valerate（P﹥0.05）. Only in 11:30, the concentrations of isovalerate caused by ration A and B were significantly higher than the other two rations(P﹤0.05).The milk yield caused by the ration C was significantly lower than the others (P﹤0.05). However, there were also no significantly differences among these four rations in the DM, fat, sugar, protein and scc of the milk. The milk fat and sugar of ration B and C were higher than ration A and D in number as well.

试验结果显示：各粗料组合日粮对各个时间点的瘤胃发酵指标：pH、TVFA、乙酸、丙酸、乙酸/丙酸、丁酸、异丁酸、戊酸浓度均无显著差异（P﹥0.05），只在11：30时，日粮A、B的异戊酸浓度显著低于日粮C、D (P﹤0.05)；日粮C的产奶量显著低于其它三个日粮，而在乳干物质、乳脂、乳糖、乳蛋白、体细胞数上，各日粮均无显著差异，从数值上看，日粮B、C的乳脂和乳糖高于A、D。

Objective:in order to compare the curative effects of using lamirudine and thymosin together with using thymosin only to the paients of chronic hepatitis b.methods:we had chosen 27 medical cases of chronic hepatitis b,which were divided into two groups:15 cases asone group,and 12 cases as the other group.let group a take 100 mglamirudine orally,qd,with half a year as a period of treatment.at the same time givethe patients injections of 100 mg thymosin,qd,for a month.to group b was only takenlamirudine.alt,tbil,the indicators of the virosis of hepatitis b (hbsag,hbeag,hbv-dna)were observed as quatos.results: at the end of the treatment, the rates that groupa and group b made hbsag transform into negative were respectively 26.67% and 16.67%(p＞0.05);hbeag:33.33%,8.33%;hbv-dna:53.33%,33.33%(p＞0.05).conclusion:combining thymic peptide with 3tc to treat chronic type b hepatitis, thymic peptide will not only promote b-cell to mature and transformation, but also to keep the subpopulation of t-cell in immune system in balance, which can enhance the reaction of matured t-cell to the antigen or other stimulus.

目的：比较拉米夫定（3tc）与胸腺肽联用和单用拉米夫定治疗慢性乙型肝炎的疗效。方法：选择慢性乙型肝炎患者27例，分为联合组15例和拉米夫定组12例；联合组用拉米夫定100 mg，口服，qd，疗程半年，合并用胸腺肽100 mg，静滴，qd，疗程1个月。拉米夫定组单用拉米夫定。以谷丙转氨酶、血清胆红素、乙肝病毒标志物(hbsag，hbeag，hbv-dna)为观察指标，比较不同治疗方案对指标的影响。结果：治疗结束时联合组与拉米夫定组对慢性乙肝患者血清hbsag阴转率分别是26.67％和16.67％(p＞0.05)；hbeag阴转率分别是33.33％和8.33％(p＞0.05)；hbv-dna阴转率分别是53.33％和33.33％(p＞0.05)。结论：胸腺肽联合3tc治疗慢乙肝，胸腺肽具有促进t淋巴细胞的成熟和转化，并维持免疫系统各t淋巴细胞亚群间的平衡作用，能增强成熟t淋巴细胞对抗原或其他刺激的反应。

The simulation test of determining the viscous resistance of the sucker rod with Ni-P-PTFE plating is conducted. The test result shows that the viscous resistance of Ni-P-PTFE plated rod in polymer solution is 20% less than that of the Ni-P plated rod, and the compound layer has better wear- and corrosion-resistance. There...

测定粘滞阻力的现场模拟实验表明，镀覆Ni P PTFE的仿抽油杆比常规镀Ni P的仿抽油杆在聚合物溶液中所受的粘滞阻力约小 2 0 %，且复合镀层具有优良的耐磨和耐蚀性，因此这种工艺对减少抽油杆磨损断裂事故，延长使用寿命具有重大意义

After being treated with Nephritis NO.1 Prescription, NO and the ET-1 contents in Model group recovered(P〈0.05)2、Nephridial tissue examination indicated that there were lessened microscopic structural pathological changes ,cellular proliferation and widening mesangial region in mesangial cells through treatment compared to Model Control , Conclusions :1 For Mesangial Proliferative Nephritis , Manshen NO.1Prescription has satisfactory therapeutic effects, It can improve symptoms, restrain accrementition in intercapillary cells and mesangial region, thus prevent nephric tubule's indurascent and prevent renal failure.2、Manshen NO.1 Prescription can increase NO contents; reduce ET-1 contents in Model control.

结果：1、与正常对照组相比，模型组血清NO含量减低(P〈0.05)，而ET-1的含量升高P〈0.05〉，给予慢肾1号方治疗后，可明显提高系膜增生性肾炎模型组血清NO(P〈0.05〉，减低血清ET-1的含量P〈0.05〉，2、肾组织学检查显示：经慢肾1号方治疗后，与模型组相比，肾小球系膜细胞增生及系膜区增宽等超微结构病变均有所减轻。

The technological process in preparation of the delafossite structure p-TCO thin films by sol-gel method is discussed systematically. The relative advantages and disadvantages of the systems of sol about organic alkoxide and inorganic salt are analyzed, and further development are discussed. It is pointed out that sol-gel method is an effective and feasible means to prepare p-TCO thin films.

本文介绍了铜铁矿结构p-TCO的结构特性以及溶胶凝胶法的基本原理和特点；系统地介绍了溶胶凝胶法制备铜铁矿结构p-TCO薄膜的工艺；分析比较了有机醇盐、无机盐溶胶体系的优缺点；最后讨论了进一步的发展方向，指出溶胶凝胶法是一种高效可行的制备p-TCO薄膜的方法。

Initiation of the 6-month treatment with bena zepril induced a signif icant drop in MABP, UAER and ACE levels in all three groups(P＜0.05), but th e reduction was significantly greater in patients with II genotype (UAER 58.6%, MABP 2.87 kPa, ACE 72.3%), compared with patients with either ID or DD geno type (P＜0.01, respectivly).

结果：苯那普利治疗后3组UAER、MABP、ACE均下降，以II型组下降幅度最大(分别为58.6%、2.87kPa和72.3%)，DD型组下降幅度最小(P＜0.05)；而Ccr在DD型组下降幅度最大，II型组下降幅度最小(P＜0.05)；多元线性逐步回归分析显示：ACE基因型对UAER下降率有显著回归效果(R2=0.72，P＜0.001)。

The NP95 1 well recorded the Heinrich event 1, Younger Dryas cold event and Bolling Allerod warm period, and the Heinrich event 1 occurred at 14.3kaB.P., Younger Dryas occurred at 11.7～10.3kaB.P..

NP95－1柱样较好地记录了Heinrich1事件、新仙女木事件以及波令－阿罗德暖期，其中Heinrich1事件发生于14.3kaB.P。，新仙女木冷期为11.7～10.3kaB.P。，10.3kaB.P。

P～WSP and P～AEP〓 were better improvers of the dough and breadmaking properties for rather soft wheat flour than P～AEP〓 and wheat bran water～insoluble pentosans.

在不同的戊聚糖组分中以P-WSP、P-AEP〓的改良效果最好，而小麦麸皮的水不溶戊聚糖组分则对面团特性和面包品质具有明显地负作用。

My first article for Screen Power Magazine, which is to this day is the official magazine of Jackie Chan, was a DVD review of the Hong Kong actioner Gen-X Cops, starring Nicholas Tse and Daniel Wu.

我的第一篇文章为屏幕力量杂志，在对这天是Jackie Chan 正式杂志，是香港actioner Gen X 警察的DVD 回顾，担任主角Nicholas Tse 和丹尼尔吴。

His lips grazed hirs, Now what are you going to do?

他的唇使吃草了 hirs，现在你将要做什麼？